→ Circulating Tumor Cells (CTCs)
→ Circulating tumor DNA (ctDNA)
→ Circulating miRNAs (cfmiRNAs)
→ Exosomes and extracellular vesicles (EVs)
→ CTC isolation and detection systems
→ Single-cell drug testing
→ Epigenetic signatures
→ Detection of minimal residual disease
→ Cancer screening for patient selection
→ Monitoring treatment response and drug resistance
→ Liquid biopsy as a treatment-selection tool in advanced cancers
Clinical trials
→ Detection of minimal residual disease
→ Cancer screening for patient selection
→ Monitoring treatment response and drug resistance
→ Liquid biopsy as a treatment-selection tool in advanced cancers
Clinical trials